Abitbol Marie, Hitte Christophe, Bossé Philippe, Blanchard-Gutton Nicolas, Thomas Anne, Martignat Lionel, Blot Stéphane, Tiret Laurent
Inserm, IMRB U955-E10, 94000, Créteil, France; Université Paris Est, Ecole nationale vétérinaire d'Alfort, 94700, Maisons-Alfort, & Faculté de médecine, 94000, Créteil, France; Etablissement Français du Sang, 94017, Créteil, France; APHP, Hôpitaux Universitaires Henri Mondor, DHU Pepsy & Centre de référence des maladies neuromusculaires GNMH, 94000 Créteil, France.
Institut de Génétique et Développement de Rennes IGDR, UMR6290 CNRS-Université de Rennes 1, Rennes, France.
PLoS One. 2015 Sep 1;10(9):e0137019. doi: 10.1371/journal.pone.0137019. eCollection 2015.
An autosomal recessive neuromuscular disorder characterized by skeletal muscle weakness, fatigability and variable electromyographic or muscular histopathological features has been described in the two related Sphynx and Devon Rex cat breeds (Felis catus). Collection of data from two affected Sphynx cats and their relatives pointed out a single disease candidate region on feline chromosome C2, identified following a genome-wide SNP-based homozygosity mapping strategy. In that region, we further identified COLQ (collagen-like tail subunit of asymmetric acetylcholinesterase) as a good candidate gene, since COLQ mutations were identified in affected humans and dogs with endplate acetylcholinesterase deficiency leading to a synaptic form of congenital myasthenic syndrome (CMS). A homozygous c.1190G>A missense variant located in exon 15 of COLQ, leading to a C397Y substitution, was identified in the two affected cats. C397 is a highly-conserved residue from the C-terminal domain of the protein; its mutation was previously shown to produce CMS in humans, and here we confirmed in an affected Sphynx cat that it induces a loss of acetylcholinesterase clustering at the neuromuscular junction. Segregation of the c.1190G>A variant was 100% consistent with the autosomal recessive mode of inheritance of the disorder in our cat pedigree; in addition, an affected, unrelated Devon Rex cat recruited thereafter was also homozygous for the variant. Genotyping of a panel of 333 cats from 14 breeds failed to identify a single carrier in non-Sphynx and non-Devon Rex cats. Finally, the percentage of healthy carriers in a European subpanel of 81 genotyped Sphynx cats was estimated to be low (3.7%) and 14 control Devon Rex cats were genotyped as wild-type individuals. Altogether, these results strongly support that the neuromuscular disorder reported in Sphynx and Devon Rex breeds is a CMS caused by a unique c.1190G>A missense mutation, presumably transmitted through a founder effect, which strictly and slightly disseminated in these two breeds. The presently available DNA test will help owners avoid matings at risk.
在两种相关的加拿大无毛猫和德文卷毛猫(家猫)品种中,描述了一种常染色体隐性神经肌肉疾病,其特征为骨骼肌无力、易疲劳以及可变的肌电图或肌肉组织病理学特征。从两只患病的加拿大无毛猫及其亲属收集的数据指出,在猫C2染色体上有一个单一的疾病候选区域,这是在基于全基因组单核苷酸多态性(SNP)的纯合性定位策略后确定的。在该区域,我们进一步确定COLQ(不对称乙酰胆碱酯酶的胶原样尾部亚基)为一个良好的候选基因,因为在患有终板乙酰胆碱酯酶缺乏症导致先天性肌无力综合征(CMS)突触形式的受影响人类和犬类中发现了COLQ突变。在两只患病猫中鉴定出一个位于COLQ第15外显子的纯合c.1190G>A错义变体,导致C397Y替换。C397是该蛋白质C末端结构域的一个高度保守残基;其突变先前已被证明在人类中会产生CMS,在此我们在一只患病的加拿大无毛猫中证实,它会导致神经肌肉接头处乙酰胆碱酯酶聚集的丧失。c.1190G>A变体的分离与我们猫系谱中该疾病的常染色体隐性遗传模式100%一致;此外,此后招募的一只患病的、无亲缘关系的德文卷毛猫该变体也是纯合的。对来自14个品种的333只猫的一组进行基因分型,在非加拿大无毛猫和非德文卷毛猫中未发现单一携带者。最后,在81只基因分型的加拿大无毛猫的欧洲亚组中,健康携带者的百分比估计较低(3.7%),14只对照德文卷毛猫被基因分型为野生型个体。总之,这些结果有力地支持了加拿大无毛猫和德文卷毛猫品种中报道的神经肌肉疾病是由一个独特的c.1190G>A错义突变引起的CMS,推测是通过奠基者效应传播的,在这两个品种中严格且轻微地传播。目前可用的DNA检测将帮助主人避免有风险的交配。